Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol. 2008;52(22):1769–81.
Article
CAS
PubMed
Google Scholar
Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Knopp RH, Nakamura H, Ridker P, Van Domburg R, Deckers JW. The benefits of statin therapy in patients without cardiovascular disease: meta-analysis of randomized controlled trials. Eur Heart J. 2009;30:510–1.
Article
Google Scholar
Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–81.
Article
CAS
PubMed
Google Scholar
Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581–90.
Article
CAS
PubMed
Google Scholar
Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD004816.
Google Scholar
Cohen JD, Brinton EA, Ito MK, Jacobson TA. Understanding Statin use in America and gaps in patient Education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol. 2012;6(3):208–15.
Article
PubMed
Google Scholar
Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–35.
Article
PubMed
Google Scholar
Puccetti L, Pasqui AL, Scarpini F, Cappellone R, Ghezzi A, Ceccatelli L, Auteri A. Statins discontinuation in compliant chronic users induces atherothrombotic profile despite baseline clinical setting and treatments. Int J Cardiol. 2011;153(3):328–9.
Article
PubMed
Google Scholar
Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. Cardiovasc Drugs Ther. 2005;19(6):403–14.
Article
CAS
PubMed
Google Scholar
McKenney JM, Davidson MH, Jacobson TA, Guyton JR. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006;97(8A):89C–94C.
Article
CAS
PubMed
Google Scholar
Cham S, Evans MA, Denenberg JO, Golomb BA. Statin-associated muscle-related adverse effects: a case series of 354 patients. Pharmacotherapy. 2010;30(6):541–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Joanisse D, Frenette J, Laflamme N, Dumont N, Gagne C, Couture P, Cote S, Piette V, Bergeron J. Statin withdrawal reduces muscle-related side effects and improves muscle function. Obes Facts. 2012;5:228.
Google Scholar
Golomb BA, Evans MA, Dimsdale JE, White HL. Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial. Arch Intern Med. 2012;172(15):1180–2.
Article
PubMed
PubMed Central
Google Scholar
Hoffman KB, Kraus C, Dimbil M, Golomb BA. A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class. PLoS One. 2012;7:8.
Google Scholar
Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fonnebo V. Chinese red yeast rice (Monascus Purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. Chin Med. 2006;1:4.
Article
PubMed
PubMed Central
Google Scholar
Lu Z, Kou W, Du B, Wu Y, Zhao S, Brusco OA, Morgan JM, Capuzzi DM, Li S. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol. 2008;101(12):1689–93.
Article
PubMed
Google Scholar
Yang CW, Mousa SA. The effect of red yeast rice (Monascus Purpureus) in dyslipidemia and other disorders. Complement Ther Med. 2012;20(6):466–74.
Article
PubMed
Google Scholar
Wang JJ, Shieh MJ, Kuo SL, Lee CL, Pan TM. Effect of red mold rice on antifatigue and exercise-related changes in lipid peroxidation in endurance exercise. Appl Microbiol Biotechnol. 2006;70(2):247–53.
Article
CAS
PubMed
Google Scholar
Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European atherosclerosis society (EAS). Eur Heart J. 2011;32(14):1769–818.
Article
PubMed
Google Scholar
Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974;15(5):443–53.
Article
CAS
PubMed
Google Scholar
Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: the fatigue assessment scale. J Psychosom Res. 2003;54(4):345–52.
Article
PubMed
Google Scholar
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.
Article
PubMed
Google Scholar
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III) final report. Circulation. 2002;106(25):3143–421.
Google Scholar
Delliaux S, Steinberg JG, Lesavre N, Paganelli F, Oliver C, Jammes Y. Effect of long-term atorvastatin treatment on the electrophysiological and mechanical functions of muscle. Int J Clin Pharmacol Ther. 2006;44(6):251–61.
Article
CAS
PubMed
Google Scholar
Dirks AJ, Jones KM. Statin-induced apoptosis and skeletal myopathy. Am J Physiol Cell Physiol. 2006;291(6):C1208–12.
Article
CAS
PubMed
Google Scholar
Mascitelli L, Pezzetta F. Physical activity in statin-treated patients. Int J Cardiol. 2009;134(1):136–7.
Article
PubMed
Google Scholar
Kwak HB, Thalacker-Mercer A, Anderson EJ, Lin CT, Kane DA, Lee NS, Cortright RN, Bamman MM, Neufer PD. Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes. Free Radic Biol Med. 2012;52(1):198–207.
Article
CAS
PubMed
Google Scholar